You are here

  • Home
  • Archive
  • Volume 107, Issue 10
  • Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)

Article metrics

Article menu
Download PDFPDF
Clinical science
Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)

 

Online download statistics by month:

Online download statistics by month: June 2022 to August 2024

AbstractFullPdf
Jun 2022217181
Jul 202246308831
Aug 202240466811
Sep 20221658326
Oct 2022353111
Nov 2022408115
Dec 202236891
Jan 202331065
Feb 20233691314
Mar 20233461611
Apr 2023343131
May 202316931
Jun 2023253126
Jul 202335241
Aug 202312553
Sep 20236123124
Oct 20236532624
Nov 20232051818
Dec 202330896
Jan 2024187136
Feb 202410741
Mar 2024105103
Apr 202414074
May 202414520
Jun 20247358
Jul 202416144
Aug 2024126105
Total16769448201